HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.

Abstract
Although ceftizoxime has been used effectively in several clinical trials for infections involving anaerobic bacteria, reports of its in-vitro activity against anaerobes are contradictory and confusing. In an effort to clarify the discrepant reports, we tested 90 strains of Bacteroides fragilis group organisms from patients with perforated or gangrenous appendicitis using eight different susceptibility testing procedures. The minimal inhibitory concentration values were dependent on the technique used; agar dilution values were often four twofold dilutions higher than microbroth dilution values. Agar techniques (including spiral gradient end point) gave values of 36% to 61% susceptible at breakpoint (depending on the technique), while the microbroth dilution techniques gave values of 84% to 92% susceptible. When a 64 micrograms/ml breakpoint for agar dilution testing was used, the methods were more comparable, with the agar methods giving values of 64% to 83% susceptible. The results of the broth disk elution procedure were difficult to read and often did not agree with other values.
AuthorsH M Wexler, S M Finegold
JournalJournal of chemotherapy (Florence, Italy) (J Chemother) Vol. 3 Suppl 2 Pg. 12-9 (Feb 1991) ISSN: 1120-009X [Print] ITALY
PMID2040893 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Ceftizoxime
Topics
  • Bacteroides fragilis (drug effects)
  • Ceftizoxime (pharmacology)
  • Double-Blind Method
  • Humans
  • Microbial Sensitivity Tests (methods)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: